THYMIC HYPERPLASIA IN GRAVES’ DISEASE

INTRODUCTION/BACKGROUNDThymic hyperplasia is a recognized but frequently underappreciated entity associated with Graves’ disease (GD). It is often misinterpreted as a mediastinal mass, potentially leading to unwarranted biopsies or surgical intervention. The underlying pathophysiological mechanisms remain poorly understood. Spontaneous regression of the mediastinal mass following euthyroidism with effective thyrotoxicosis treatment supports a benign etiology. Here, we present a case of a young female with GD and an incidentally discovered anterior mediastinal mass, highlighting the diagnostic complexities that necessitated a multidisciplinary approach. CASEA 21-year-old female presenting with a large goiter, a thyrotoxic state (FT4 >100 pmol/L, TSH 0.01 mU/ml and anti-TSH receptor Ab >40 IU/L) with no thyroid ophthalmopathy was diagnosed with GD. Despite medical management, adequate control of her thyroid hormone levels proved to be challenging, prompting a surgical consultation for a potential thyroidectomy. To assess the extent of the goiter, computed tomography (CT) imaging was performed, revealing a grossly enlarged thyroid gland with mild tracheal narrowing and a well-defined, solid, enhancing 5.6 cm × 6.4 cm × 4.3 cm anterior mediastinal mass. Given the initial concern for an ectopic thyroid gland or malignancy, performing an invasive biopsy was considered. However, a multidisciplinary team consisting of experts from endocrinology, surgery, respiratory medicine, radiology, and nuclear medicine reviewed the findings and concluded that the mass was most consistent with thymic hyperplasia. Considering the high surgical risk, a conservative approach was pursued, with the patient undergoing radioiodine therapy for thyrotoxicosis and serial imaging to monitor the mediastinal mass. Long-term outcomes are yet to be seen. CONCLUSIONThis case underscores the diagnostic challenges posed by thymic hyperplasia in patients with GD and the potential for misdiagnosis as a mediastinal pathology. Awareness of this association is crucial in order to avoid unnecessary surgical interventions. A multidisciplinary approach is essential for accurate diagnosis and optimal management, promoting a conservative therapeutic strategy when appropriate.

Authors

Publication Details

Journal
Journal of the ASEAN Federation of Endocrine Societies
Published
2025-05-30
DOI
https://doi.org/10.15605/jafes.040.s1.013
Primary Topic
Myasthenia Gravis and Thymoma
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

THYMIC HYPERPLASIA IN GRAVES’ DISEASE

Laura M. Yee, Kuo‐Liong Chien
Journal of the ASEAN Federation of Endocrine Societies
Myasthenia Gravis and Thymoma
article

THYMIC HYPERPLASIA IN GRAVES’ DISEASE

Laura M. Yee, Kuo‐Liong Chien
article en

Abstract

INTRODUCTION/BACKGROUNDThymic hyperplasia is a recognized but frequently underappreciated entity associated with Graves’ disease (GD). It is often misinterpreted as a mediastinal mass, potentially leading to unwarranted biopsies or surgical intervention. The underlying pathophysiological mechanisms remain poorly understood. Spontaneous regression of the mediastinal mass following euthyroidism with effective thyrotoxicosis treatment supports a benign etiology. Here, we present a case of a young female with GD and an incidentally discovered anterior mediastinal mass, highlighting the diagnostic complexities that necessitated a multidisciplinary approach. CASEA 21-year-old female presenting with a large goiter, a thyrotoxic state (FT4 >100 pmol/L, TSH 0.01 mU/ml and anti-TSH receptor Ab >40 IU/L) with no thyroid ophthalmopathy was diagnosed with GD. Despite medical management, adequate control of her thyroid hormone levels proved to be challenging, prompting a surgical consultation for a potential thyroidectomy. To assess the extent of the goiter, computed tomography (CT) imaging was performed, revealing a grossly enlarged thyroid gland with mild tracheal narrowing and a well-defined, solid, enhancing 5.6 cm × 6.4 cm × 4.3 cm anterior mediastinal mass. Given the initial concern for an ectopic thyroid gland or malignancy, performing an invasive biopsy was considered. However, a multidisciplinary team consisting of experts from endocrinology, surgery, respiratory medicine, radiology, and nuclear medicine reviewed the findings and concluded that the mass was most consistent with thymic hyperplasia. Considering the high surgical risk, a conservative approach was pursued, with the patient undergoing radioiodine therapy for thyrotoxicosis and serial imaging to monitor the mediastinal mass. Long-term outcomes are yet to be seen. CONCLUSIONThis case underscores the diagnostic challenges posed by thymic hyperplasia in patients with GD and the potential for misdiagnosis as a mediastinal pathology. Awareness of this association is crucial in order to avoid unnecessary surgical interventions. A multidisciplinary approach is essential for accurate diagnosis and optimal management, promoting a conservative therapeutic strategy when appropriate.

Journal of the ASEAN Federation of Endocrine SocietiesVol. 40(S1)
Openalex Percentile: Top 80%
Myasthenia Gravis and Thymoma
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.